ArticleInternational journal of ophthalmology2026
An intelligent segmentation method for leakage points in central serous chorioretinopathy based on fluorescein angiography images.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo construct an intelligent segmentation scheme for precise localization of central serous chorioretinopathy (CSC) leakage points, thereby enabling ophthalmologists to deliver accurate laser treatment without navigational laser equipment.
methodsA dataset with dual labels (point-level and pixel-level) was first established based on fundus fluorescein angiography (FFA) images of CSC and subsequently divided into training (102 images), validation (40 images), and test (40 images) datasets. An intelligent segmentation method was then developed, based on the You Only Look Once version 8 Pose Estimation (YOLOv8-Pose) model and segment anything model (SAM), to segment CSC leakage points. Next, the YOLOv8-Pose model was trained for 200 epochs, and the best-performing model was selected to form the optimal combination with SAM. Additionally, the classic five types of U-Net series models [
resultsWith the increase of training epochs, the mAP50-95, Recall, and precision of the YOLOv8-Pose model showed a significant increase and tended to stabilize, and it achieved a preliminary localization success rate of 90% (
conclusionBy combining the precise localization capability of the YOLOv8-Pose model with the robust and flexible segmentation ability of SAM, the proposed method not only demonstrates the effectiveness of the YOLOv8-Pose model in detecting keypoint coordinates of CSC leakage points from the perspective of application innovation but also establishes a novel approach for accurate segmentation of CSC leakage points through the "detect-then-segment" strategy, thereby providing a potential auxiliary means for the automatic and precise real-time localization of leakage points during traditional laser photocoagulation for CSC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.